ASHG 2016

Author:

QIAGEN Digital Insights

ASHG 2016

Sample to insight solutions for liquid biopsy, hereditary diseases, and RNA-seq

Meet us at ASHG 2016
Together with leading scientists and clinicians from around the world we will present recent findings at ASHG in Vancouver, Canada October 18-22. You can meet us in the exhibit hall where we’ll have a series of presentations in our booth, at the poster sessions, or you can join our workshop where invited speakers will present their NGS sample to insight solutions.

Workshop

Sample to Insight NGS solutions: Multimodal liquid biopsy WGS, trio and family analyses, and RNA sequencing analysis and interpretation
Date and time: Thursday, October 20, 2016 at 1:00 p.m. – 2:30 p.m.
Location: Room 13, East building, Convention Center

Speakers:

  • Sample to Insight Introduction, Jason Gammack, VP of Marketing Life Sciences, QIAGEN
  • Multi-modal Liquid Biopsy Whole Genome Sequencing to characterize tumor heterogeneity and evolution, Dr. Mark Cowley, Team Leader – Translational Genomics / Sr. Bioinformatics Research Officer, Garvan Institute
  • Rapid identification and prioritization of pathogenic variants associated with anomalies of the kidneys and urinary tract, Helge Martens, M.Sc., Department of Human Genetics, Hannover Medical School, Germany
  • Comparative transcriptome analyses of Hepatocellular Carcinoma and Endometrioid Endometrial Carcinoma highlight common molecular and biological processes, Jean-Noel Billaud, Ph.D., Principal Scientist, QIAGEN Bioinformatics

In-booth presentations

You are welcome to visit us at booth #1234 during the exhibition hours. Our experts will be there to discuss and present our solutions and will also host the following in-booth presentations:

Wednesday October 19

10:30 a.m. / 2:45 p.m.   Comparative transcriptome analyses of HCC and EEC highlight common molecular and biological processes
10:45 a.m. / 3:00 p.m.   QIAseq Targeted NGS: Digital Sequencing for high performance mutation detection
12:45 p.m.   QIAGEN Clinical Insight – Clinical interpretation and reporting of complex NGS data, made simple
1:15 p.m.   Sample-to-Insight from Cell-free DNA

Thursday October 20

10:30 a.m. / 2:45 p.m.   HGMD: Comprehensive coverage of published inherited disease mutations
10:45 a.m. / 3:00 p.m.   Prioritizing causal variants for rare, inherited syndromes, using patient phenotypes
12:45 p.m.   QIAGEN Clinical Insight – Clinical interpretation and reporting of complex NGS data, made simple
1:15 p.m.   Sample-to-Insight from Cell-free DNA

Poster presentations

Phenotypic-Driven Prioritization of Trio-Based Whole Genome Sequencing Data for Congenital Disorders
Presented by Alina Khromykh on Thursday, October 20 at 2:00 p.m. – 3:00 p.m.
Poster# 1721T, Bioinformatics and Computational, Exhibit Hall B, West Building

Sensitive and Reliable Variant Detection From Challenging Samples
Presented by Nan Fang on Thursday, October 20 at 2:00 p.m. – 3:00 p.m.
Poster# 2873T, Cancer Genetics, Exhibit Hall B, West Building

Implementing molecular barcode counting into a comprehensive integrated targeted sequencing portfolio and bioinformatics pipeline
Presented by Eric Lader on Thursday, October 20 at 3:00 p.m. – 4:00 p.m.
Poster# 728T, Molecular and Cytogenetic Diagnostics, Exhibit Hall B, West Building

Leveraging an Advanced Knowledge Base of Biological Pathways and Network Analytics to Identify Disease-Causing Mutations from Clinical Genome and Exome Sequence Data with Increased Efficiency and Accuracy
Presented by Sohela Shah on Friday, October 21 at 2:00 p.m. – 3:00 p.m.
Poster# 1761F, Bioinformatics and Computational, Exhibit Hall B, West Building

miRNA as liquid biopsy biomarkers in cancer
Presented by Brian Dugan on Friday, October 21 at 2:00 p.m. – 3:00 p.m.
Poster# 2892F, Cancer Genetics, Exhibit Hall B, West Building

More information

For more details about ASHG 2016, please visit the official event page.
You can find more information about all QIAGEN solutions at qiagen.com.